Home / Brands / Breckenridge Pharmaceutical
Breckenridge Pharmaceutical Recalls
35 recalls on record · November 18, 2015 to June 17, 2026 · Drugs
Recalls by year
15
18
20
21
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
March 25, 2020DrugsFDA
Breckenridge Pharmaceutical, Inc recalls Solifenacin Succinate Tablets, 10 mg, packaged in a) 30-count bottles (NDC 51991-894-33) and b) 90-count bottles (NDC 51
Hazard: CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.
March 25, 2020DrugsFDA
Breckenridge Pharmaceutical, Inc recalls Solifenacin Succinate Tablets, 5mg, packaged in a) 30-count bottles (NDC 51991-893-33) and b) 90-count bottles (NDC 5199
Hazard: CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.
March 4, 2020DrugsFDA
Breckenridge Pharmaceutical, Inc recalls Zoledronic Acid Injection 5 mg/100 mL (0.05 mg/mL), Solution for Intravenous Infusion, Sterile Solution, 100 mL Single -
Hazard: Failed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing.
November 21, 2018DrugsFDA
Breckenridge Pharmaceutical, Inc. recalls Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical,
Hazard: Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.
November 18, 2015DrugsFDA
Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-release Capsules, USP, 60 mg, Rx Only, 1000 count bottle, Manufactured by: Laboratorios Dr. Esteve, S
Hazard: Presence of Foreign Tablets/Capsules: one foreign capsule identified as omeprazole 10 mg was found in the bottle